Search Results - Kathleen Tenner
- Showing 1 - 9 results of 9
-
1
Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831 by Nadine Norton, Rebecca M. Olson, Mark D. Pegram, Kathleen Tenner, Karla V. Ballman, Raphael Clynes, Keith L. Knutson, Edith A. Perez
Published 2014Artigo -
2
Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria by Edith A. Perez, Amylou C. Dueck, Ann E. McCullough, Monica M. Reinholz, Kathleen Tenner, Nancy E. Davidson, Julie R. Gralow, Lyndsay N. Harris, Leila A. Kutteh, David W. Hillman, Robert B. Jenkins, Beiyun Chen
Published 2011Artigo -
3
<i>Cytokeratin-19</i> and <i>Mammaglobin</i> Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Tria... by Monica M. Reinholz, Kathleen Kitzmann, Kathleen Tenner, David W. Hillman, Amylou C. Dueck, Timothy J. Hobday, Donald W. Northfelt, Alvaro Moreno‐Aspitia, Vivek Roy, Betsy LaPlant, Jake Allred, Philip J. Stella, Wilma L. Lingle, Edith A. Perez
Published 2011Artigo -
4
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain by Keith L. Knutson, Raphael Clynes, Barath Shreeder, Patrick Yeramian, Kathleen P. Kemp, Karla V. Ballman, Kathleen Tenner, Courtney L. Erskine, Nadine Norton, Donald W. Northfelt, Winston Tan, Carmen Calfa, Mark D. Pegram, Elizabeth A. Mittendorf, Edith A. Perez
Published 2016Artigo -
5
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2‐positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North C... by Alvaro Moreno‐Aspitia, David W. Hillman, Stephen Dyar, Kathleen Tenner, Julie R. Gralow, Peter A. Kaufman, Nancy E. Davidson, Jacqueline M. Lafky, Monica M. Reinholz, Wilma L. Lingle, Leila A. Kutteh, Walter P. Carney, Amylou C. Dueck, Edith A. Perez
Published 2013Artigo -
6
<i>HER2</i> and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial by Edith A. Perez, Monica M. Reinholz, David W. Hillman, Kathleen Tenner, Matthew Schroeder, Nancy E. Davidson, Silvana Martino, George W. Sledge, Lyndsay N. Harris, Julie R. Gralow, Amylou C. Dueck, Rhett P. Ketterling, James N. Ingle, Wilma L. Lingle, Peter A. Kaufman, Daniel W. Visscher, Robert B. Jenkins
Published 2010Artigo -
7
Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial by Edith A. Perez, E. Aubrey Thompson, Karla V. Ballman, S. Keith Anderson, Yan W. Asmann, Krishna R. Kalari, Jeanette E. Eckel‐Passow, Amylou C. Dueck, Kathleen Tenner, Jin Jen, Jian-Bing Fan, Xochiquetzal J. Geiger, Ann E. McCullough, Beiyun Chen, Robert B. Jenkins, George W. Sledge, Eric P. Winer, Julie R. Gralow, Monica M. Reinholz
Published 2015Artigo -
8
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer by Jodi M. Carter, Saranya Chumsri, Douglas Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh, David W. Hillman, Kathleen Tenner, Jennifer M. Kachergus, Heather Ann Brauer, Sarah Warren, David Henderson, Ji Shi, Yi Liu, Heikki Joensuu, Henrik Lindman, Roberto A. Leon‐Ferre, Judy C. Boughey, Minetta C. Liu, James N. Ingle, Krishna R. Kalari, Fergus J. Couch, Keith L. Knutson, Matthew P. Goetz, Edith A. Perez, E. Aubrey Thompson
Published 2023Artigo -
9
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03) by Michael Gnant, Amylou C. Dueck, Sophie Frantal, Miguel Martín, H.J. Burstein, Richard Greil, Peter Fox, Antonio C. Wolff, Arlene Chan, Eric P. Winer, Georg Pfeiler, Kathy D. Miller, Marco Colleoni, Jennifer M. Suga, Gabor Rubovsky, Judith M. Bliss, Ingrid A. Mayer, Christian F. Singer, Zbigniew Nowecki, Olwen Hahn, Jacqui Thomson, Norman Wolmark, Kepa Amillano, Hope S. Rugo, Guenther G. Steger, Blanca Hernando Fernández de Aranguiz, Tufia C. Haddad, Antonia Perelló, Meritxell Bellet, Hannes Fohler, Otto Metzger, Anita Jallitsch-Halper, Kadine Solomon, Céline Schurmans, K. P. Theall, Dongrui R. Lu, Kathleen Tenner, Christian Fesl, Angela DeMichele, Erica L. Mayer
Published 2021Artigo
Search Tools:
Related Subjects
Breast cancer
Cancer
Internal medicine
Medicine
Oncology
Trastuzumab
Chemotherapy
Confidence interval
Hazard ratio
Adjuvant
Biology
Biochemistry
Gene
Immune system
Immunology
Metastatic breast cancer
Immunohistochemistry
Proportional hazards model
Adjuvant therapy
Antibody
Biomarker
Cancer research
Capecitabine
Chromosome
Chromosome 17 (human)
Circulating tumor cell
Clinical endpoint
Clinical trial
Colorectal cancer
Concordance